Description
Evista is a selective estrogen receptor modulator (SERM) that belongs to
the benzothiophene class of compounds. The chemical designation is methanone,
[6-hydroxy-2-(4-hydroxyphenyl) benzo[b] thien-3-yl] - [4-[2-(1-piperidinyl)
ethoxy] phenyl]-, hydrochloride. Raloxifene hydrochloride (HCl) has the
empirical formula C28H27NO4S° HCl, which corresponds to a molecular
weight of 510.05. Raloxifene HCl is an off-white to pale-yellow solid that
is very slightly soluble in water.
This medicine is supplied in a tablet dosage form for oral administration.
Each tablet of Evista contains 60 mg of raloxifene HCl, which is the molar
equivalent of 55.71 mg of free base. Anhydrous lactose, carnauba wax, crospovidone,
FD& C Blue No. 2 aluminum lake, hypromellose, lactose monohydrate, magnesium
stearate, modified pharmaceutical glaze, polyethylene glycol, polysorbate
80, povidone, propylene glycol, and titanium dioxide are the inactive ingredients
of Evista. |
